Protagen Diagnostics Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 32

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

Protagen Diagnostics General Information

Description

Developer of diagnostic tests designed to provide treatment of autoimmune diseases. The company's biomarker discovery platform is used for the detection of autoantibodies in individuals undergoing cancer immunotherapy, as a means of predicting treatment response and guiding therapeutic decisions, enabling patients to begin treatment more quickly and result in a higher likelihood of successful treatment.

Contact Information

Website
protagen.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Otto-Hahn-Street 15
  • 44227 Dortmund
  • Germany
Primary Industry
Diagnostic Equipment
Acquirer
Oncimmune
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Otto-Hahn-Street 15
  • 44227 Dortmund
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Protagen Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Protagen Diagnostics‘s full profile, request access.

Request a free trial

Protagen Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of diagnostic tests designed to provide treatment of autoimmune diseases. The company's biomarker discovery pl
Diagnostic Equipment
Dortmund, Germany
32 As of 2006

Fremont, CA
 

Cambridge, MA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Protagen Diagnostics Competitors (4)

One of Protagen Diagnostics’s 4 competitors is BioGenex Laboratories, a Corporation company based in Fremont, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioGenex Laboratories Corporation Fremont, CA
AnTolRx Venture Capital-Backed Cambridge, MA
NexImmune Formerly VC-backed Gaithersburg, MD
IPI Legacy Liquidation Formerly VC-backed Seattle, WA
To view Protagen Diagnostics’s complete competitors history, request access »

Protagen Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Protagen Diagnostics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Protagen Diagnostics‘s full profile, request access.

Request a free trial

Protagen Diagnostics FAQs

  • When was Protagen Diagnostics founded?

    Protagen Diagnostics was founded in 1997.

  • Where is Protagen Diagnostics headquartered?

    Protagen Diagnostics is headquartered in Dortmund, Germany.

  • What is the size of Protagen Diagnostics?

    Protagen Diagnostics has 32 total employees.

  • What industry is Protagen Diagnostics in?

    Protagen Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Protagen Diagnostics a private or public company?

    Protagen Diagnostics is a Private company.

  • What is the current valuation of Protagen Diagnostics?

    The current valuation of Protagen Diagnostics is .

  • What is Protagen Diagnostics’s current revenue?

    The current revenue for Protagen Diagnostics is .

  • How much funding has Protagen Diagnostics raised over time?

    Protagen Diagnostics has raised $30.1M.

  • Who are Protagen Diagnostics’s investors?

    Dusseldorf (site), KfW Group, MIG AG, Münchener Rückversicherungs-Gesellschaft, and NRW.Bank are 5 of 7 investors who have invested in Protagen Diagnostics.

  • Who are Protagen Diagnostics’s competitors?

    BioGenex Laboratories, AnTolRx, NexImmune, and IPI Legacy Liquidation are competitors of Protagen Diagnostics.

  • When was Protagen Diagnostics acquired?

    Protagen Diagnostics was acquired on 19-Mar-2019.

  • Who acquired Protagen Diagnostics?

    Protagen Diagnostics was acquired by Oncimmune.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »